2015
DOI: 10.1038/icb.2015.84
|View full text |Cite
|
Sign up to set email alerts
|

Allergen‐induced interleukin‐18 promotes experimental eosinophilic oesophagitis in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
10
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 7 publications
(14 citation statements)
references
References 0 publications
4
10
0
Order By: Relevance
“…In recent years, there has been major progress in understanding the involvement of eosinophil and mast cell accumulation esophageal remodeling and functional esophageal abnormalities; however, the mode of EoE induction, its progression, diagnosis and it management are currently not well proven [11,13,58,59,8385]. EoE was first described in 1978 and clinically recognized in 1994 further it was well accepted with distinct characteristics and nomenclature in 2007, and was recently updated in 2011 [86–89].…”
Section: Eosinophilic Esophagitismentioning
confidence: 99%
See 3 more Smart Citations
“…In recent years, there has been major progress in understanding the involvement of eosinophil and mast cell accumulation esophageal remodeling and functional esophageal abnormalities; however, the mode of EoE induction, its progression, diagnosis and it management are currently not well proven [11,13,58,59,8385]. EoE was first described in 1978 and clinically recognized in 1994 further it was well accepted with distinct characteristics and nomenclature in 2007, and was recently updated in 2011 [86–89].…”
Section: Eosinophilic Esophagitismentioning
confidence: 99%
“…But, there are limitations that exist with oral swallowed steroids therapy: dependency on treatment (reoccurrence of EoE symptoms within few months after discontinuation of therapy). Our, most recent report indicates that IL-18 and iNKT cells are induced in EoE patients and IL-18 activate iNKT cells; therefore neutralization of iNKT cells, IL-18 or IL8Rα may be a possible therapeutic target for EoE [124,125]. Taken together, much progress has been made concerning the EGID therapy, but there is still lack of mechanistic understanding compared with other cell types and gastrointestinal diseases like IBD.…”
Section: Treatment Strategies Of Egidmentioning
confidence: 99%
See 2 more Smart Citations
“…Interestingly, it has been suggested that milk lipids could also be the driving force in another iNKT cell dependent allergic inflammation (Jyonouchi et al 2014). Eosinophilic esophagitis (EoE) is a chronic allergic inflammation of the esophagus (Wechsler and Bryce 2014), and mouse models demonstrated that iNKT cells and their Th2 cytokines are required for the disease (Dutt et al 2015;Rajavelu et al 2012;Rayapudi et al 2014). In EoE patients, iNKT cell numbers and Th2 cytokines are increased in the esophagus (Jyonouchi et al 2014;Lexmond et al 2014;Rayapudi et al 2014) and normalize following dietary removal of the allergen (Lexmond et al 2014).…”
Section: Further Aspects Of Environmental Inkt Cell Antigensmentioning
confidence: 99%